A short double-stapled peptide inhibits respiratory syncytial virus entry and spreading

Autor: Geneviève Mottet-Osman, Origène Nyanguile, Elodie Baechler, Miriam Arrell, Abdelhak Boukadiri, Ronan Le Goffic, Marie Galloux, Julien Héritier, Thibaut Larcher, Marie-Anne Rameix-Welti, Jean-Manuel Segura, Vanessa Gaillard, Dominique Garcin, Jean-François Eléouët
Přispěvatelé: Haute École Spécialisée de Suisse occidentale Valais (HES-SO Valais-Wallis), Unité de recherche Virologie et Immunologie Moléculaires (VIM (UR 0892)), Institut National de la Recherche Agronomique (INRA), Université Paris-Saclay, Department of Microbiology and Molecular Medicine, University of Geneva [Switzerland], Physiopathologie Animale et bioThérapie du muscle et du système nerveux (PAnTher), Institut National de la Recherche Agronomique (INRA)-Ecole Nationale Vétérinaire, Agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS), Laboratoire de Microbiologie, Hôpital Raymond Poincareé, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Génétique Animale et Biologie Intégrative (GABI), Institut National de la Recherche Agronomique (INRA)-AgroParisTech, Commission for Technology and Innovation CTI [12.868.1], Swiss Confederation, Unité de recherche Virologie et Immunologie Moléculaires (VIM), Développement et Pathologie du Tissu Musculaire (DPTM), Institut National de la Recherche Agronomique (INRA)-Ecole Nationale Vétérinaire de Nantes, UFR des Sciences de la Santé Simone Veil
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Protein Conformation
alpha-Helical

viruses
respiratory syncytial virus
[SDV]Life Sciences [q-bio]
Peptide
Plasma protein binding
Respiratory syncytial virus
stapled peptides
Virus Replication
respiratory syncytial viruses
Mice
Pharmacology (medical)
Peptide sequence
chemistry.chemical_classification
ddc:616
Mice
Inbred BALB C

Protein Stability
virus respiratoire syncytial
3. Good health
Amino acid
Stapled peptides
Infectious Diseases
Female
Protein Binding
Respiratory Syncytial Virus Infections
Biology
Antiviral Agents
Virus
03 medical and health sciences
Viral entry
Animals
Humans
Protein Interaction Domains and Motifs
Amino Acid Sequence
Administration
Intranasal

Pharmacology
Binding Sites
Sequence Homology
Amino Acid

Virus Internalization
Virology
Heptad repeat
030104 developmental biology
chemistry
Viral replication
Amino Acid Substitution
Respiratory Syncytial Virus
Human

Proteolysis
Peptides
Sequence Alignment
Viral Fusion Proteins
HeLa Cells
Zdroj: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2017, 61 (4), ⟨10.1128/AAC.02241-16⟩
Antimicrobial Agents and Chemotherapy, Vol. 61, No 4 (2017)
Antimicrobial Agents and Chemotherapy 4 (61), . (2017)
ISSN: 0066-4804
1098-6596
Popis: Synthetic peptides derived from the heptad repeat (HR) of fusion (F) proteins can be used as dominant negative inhibitors to inhibit the fusion mechanism of class I viral F proteins. Here, we have performed a stapled-peptide scan across the HR2 domain of the respiratory syncytial virus (RSV) F protein with the aim to identify a minimal domain capable of disrupting the formation of the postfusion six-helix bundle required for viral cell entry. Constraining the peptides with a single staple was not sufficient to inhibit RSV infection. However, the insertion of double staples led to the identification of novel short stapled peptides that display nanomolar potency in HEp-2 cells and are exceptionally robust to proteolytic degradation. By replacing each amino acid of the peptides by an alanine, we found that the substitution of residues 506 to 509, located in a patch of polar contacts between HR2 and HR1, severely affected inhibition. Finally, we show that intranasal delivery of the most potent peptide to BALB/c mice significantly decreased RSV infection in upper and lower respiratory tracts. The discovery of this minimal HR2 sequence as a means for inhibition of RSV infection provides the basis for further medicinal chemistry efforts toward developing RSV fusion antivirals.
Databáze: OpenAIRE